A booster dose of Sinovac Covid-19 vaccine following a two-shot regimen does not offer adequate protection against the fast spreading Omicron variant, a laboratory study has…
Gilead Sciences and Novo Nordisk have agreed to expand their clinical collaboration in non-alcoholic steatohepatitis (NASH) to conduct a…
Canadian firm Arch Biopartners has secured approval to make certain protocol amendments to the Phase II trial of its…
Gilead Sciences and Merck have signed an agreement to co-develop and co-commercialise long-acting treatments for HIV.
Canada’s Medicago has started a late-stage study of its plant-derived Covid-19 vaccine candidate combined with GSK's pandemic adjuvant.
American pharmaceutical and biotechnology company Moderna has started an early-stage study of a new Covid-19 vaccine candidate.
Sanofi’s vaccine division Sanofi Pasteur and Translate Bio have initiated the Phase I/II clinical trial to their messenger RNA…
The Government of the US has signed an agreement with Moderna to procure 100 million doses of its potential…
South Korea-based biomedicine maker Samsung Biologics has unveiled plans to build its fourth plant this year to boost its…